Veritable’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-1,143
| Closed | -$281K | – | 899 |
|
2022
Q3 | $281K | Sell |
1,143
-6
| -0.5% | -$1.48K | 0.01% | 649 |
|
2022
Q2 | $284K | Buy |
1,149
+95
| +9% | +$23.5K | 0.01% | 699 |
|
2022
Q1 | $349K | Buy |
1,054
+28
| +3% | +$9.27K | 0.01% | 660 |
|
2021
Q4 | $369K | Sell |
1,026
-23
| -2% | -$8.27K | 0.01% | 640 |
|
2021
Q3 | $341K | Buy |
1,049
+29
| +3% | +$9.43K | 0.01% | 645 |
|
2021
Q2 | $318K | Buy |
1,020
+8
| +0.8% | +$2.49K | 0.01% | 659 |
|
2021
Q1 | $323K | Buy |
+1,012
| New | +$323K | 0.01% | 633 |
|
2019
Q4 | – | Sell |
-1,349
| Closed | -$240K | – | 836 |
|
2019
Q3 | $240K | Buy |
1,349
+408
| +43% | +$72.6K | ﹤0.01% | 715 |
|
2019
Q2 | $245K | Sell |
941
-88
| -9% | -$22.9K | ﹤0.01% | 706 |
|
2019
Q1 | $294K | Buy |
+1,029
| New | +$294K | 0.01% | 651 |
|
2018
Q3 | – | Sell |
-673
| Closed | -$275K | – | 836 |
|
2018
Q2 | $275K | Buy |
+673
| New | +$275K | 0.01% | 663 |
|